$3.79
-0.310 (-7.56%)
At Close: Jun 03, 2026
NEW ORLEANS , May 30, 2025 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 15, 2025 to file lead plaintiff applications in a securities
Investors Urged to Contact Levi & Korsinsky for Information Before July 14, 2025 - Iovance Biotherapeutics, Inc. (IOVA)
04:00pm, Friday, 30'th May 2025
NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
SAN DIEGO, May 30, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Iovance Biotherap
NEW YORK CITY, NY / ACCESS Newswire / May 30, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
Lost Money on Iovance Biotherapeutics, Inc. (IOVA)? Contact Levi & Korsinsky Before July 14, 2025 to Join Class Action
02:00pm, Friday, 30'th May 2025
NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
Lost Money on Iovance Biotherapeutics, Inc. (IOVA)? Urged to Join Class Action Before July 14, 2025 - Contact Levi & Korsinsky
12:25pm, Friday, 30'th May 2025
NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
Iovance Biotherapeutics, Inc. (IOVA) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 14, 2025 Deadline
11:00am, Friday, 30'th May 2025
NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
IOVA Investors Have the Opportunity to Lead the Iovance Biotherapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
10:35am, Friday, 30'th May 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Iovance To Contact Him Directly To Discuss Their Options If you su
Class Action Filed Against Iovance Biotherapeutics, Inc. (IOVA) - July 14, 2025 Deadline to Join - Contact Levi & Korsinsky
05:45am, Friday, 30'th May 2025
NEW YORK , May 30, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Iovance Biotherapeutics, Inc. ("Iovance" or the "Company") (NASDAQ: IOVA) of a class action securities lawsuit. CLAS
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed aga
July 14, 2025 Deadline Approaching: Join Class Action Against Iovance Biotherapeutics, Inc. (IOVA) - Contact Levi & Korsinsky
12:25pm, Thursday, 29'th May 2025
NEW YORK, NY / ACCESS Newswire / May 29, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
Investors in Iovance Biotherapeutics, Inc. Should Contact The Gross Law Firm Before July 14, 2025 to Discuss Your Rights – IOVA
12:15pm, Thursday, 29'th May 2025
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA).
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, alerts investors that a securities cl
Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
12:00pm, Thursday, 29'th May 2025
LOS ANGELES , May 29, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Iovance Biotherap
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Iovance Biotherapeutics, Inc. (IOVA) Investors of July 14, 2025 Deadline
11:15am, Thursday, 29'th May 2025
NEW YORK, NY / ACCESS Newswire / May 29, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
Sign In
Buy IOVA